APC Anti-Human CD22 Antibody[BU59]

Introducing the APC Anti-Human CD22 Antibody [BU59], a highly efficient and reliable solution for immunological research and diagnostics. This product is designed to facilitate the detection and analysis of CD22, a cell surface glycoprotein predominantly expressed on B cells.

With a generous size of 200 tests, this antibody offers an ample supply to support a wide range of experimental applications. Its superior quality ensures consistent and accurate results, enabling researchers to obtain valuable insights into the role of CD22 in various biological processes.

The APC Anti-Human CD22 Antibody [BU59] is meticulously manufactured using advanced techniques, guaranteeing exceptional specificity and sensitivity. Its affinity for CD22 allows for precise identification and quantification of this target molecule, contributing to a deeper understanding of B cell biology and related disorders.

This antibody is compatible with a variety of immunological techniques, including flow cytometry, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into existing laboratory protocols, facilitating efficient and streamlined workflows.

Furthermore, the APC Anti-Human CD22 Antibody [BU59] is meticulously validated to ensure optimal performance and reproducibility. Rigorous quality control measures are implemented throughout the production process, guaranteeing batch-to-batch consistency and reliability.

In summary, the APC Anti-Human CD22 Antibody [BU59] is a premium product that offers researchers a powerful tool for investigating CD22 biology. Its large size, exceptional quality, and compatibility with various techniques make it an indispensable asset in immunological research and diagnostic applications. Trust in this antibody to deliver accurate and reliable results, enabling groundbreaking discoveries in the field of B cell biology.